Viking Therapeutics, Inc. VKTX
652 filings, 3 in the last 30 days
SEC filing indexWhat the 8-Ks said
1 event in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Apr 23, 2025 Auditor changeChanged the accounting firm that audits it 8-K item 4.01 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 40 events
- Oct 29, 2026 Planned sale Charles A. Rowland (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 128,000 shares
- Oct 29, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 28, 2026 8-K Quarterly results8-K item 2.02
- Sep 28, 2026 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- Sep 25, 2026 Offering Convertible notes: $225M424B5 · We are offering $225,000,000 aggregate principal amount of our 2.00% convertible senior notes due 2032.
- Sep 25, 2026 Offering Convertible notes424B5 · We are offering 7,857,143 shares of our common stock in this offering.
- Sep 22, 2026 8-K Other events8-K item 8.01
- Jul 30, 2026 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · We may offer and sell, from time to time in one or more offerings, any combination of the securities identified above, either individually or in combination with other securities.
- Jul 29, 2026 Planned sale MARIANNA MANCINI (Officer) gave notice of a planned sale of 18,217 shares worth about $610KForm 144, approximate sale date Jul 29, 2026
- Jul 29, 2026 Planned sale GREG ZANTE (Officer) gave notice of a planned sale of 21,217 shares worth about $710KForm 144, approximate sale date Jul 29, 2026
- Jul 29, 2026 Planned sale BRIAN LIAN (Officer) gave notice of a planned sale of 148,517 shares worth about $4.9MForm 144, approximate sale date Jul 29, 2026
- Jul 29, 2026 8-K Quarterly results8-K item 2.02
- Jul 29, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- May 26, 2026 8-K Shareholder vote results8-K item 5.07
- Apr 30, 2026 Planned sale Brian Lian (Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 365,000 shares
- Apr 30, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 29, 2026 8-K Quarterly results8-K item 2.02
- Feb 11, 2026 Auditor Auditor changed: Marcum LLP → CBIZ CPAs P.C.auditor named in the 10-K
- Feb 11, 2026 8-K Quarterly results8-K item 2.02
- Feb 11, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Jan 5, 2026 Planned sale BRIAN LIAN (Officer) gave notice of a planned sale of 233,409 shares worth about $7.7MForm 144, approximate sale date Jan 5, 2026
- Jan 5, 2026 Planned sale GREG ZANTE (Officer) gave notice of a planned sale of 57,661 shares worth about $1.9MForm 144, approximate sale date Jan 5, 2026
- Jan 5, 2026 Planned sale MARIANNA MANCINI (Officer) gave notice of a planned sale of 57,661 shares worth about $1.9MForm 144, approximate sale date Jan 5, 2026
- Jan 2, 2026 Planned sale MATTHEW W. FOEHR (Director) gave notice of a planned sale of 16,000 shares worth about $562KForm 144, approximate sale date Jan 2, 2026
- Oct 23, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Oct 22, 2025 8-K Quarterly results8-K item 2.02
- Aug 19, 2025 8-K Regulation FD disclosure8-K item 7.01
- Jul 23, 2025 8-K Quarterly results8-K item 2.02
- Jul 23, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- May 27, 2025 8-K Shareholder vote results8-K item 5.07
- Apr 24, 2025 Planned sale Brian Lian (Chief Executive Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 365,000 shares
- Apr 24, 2025 Planned sale Marianne Mancini (Chief Operations Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 147,812 shares
- Apr 24, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Apr 23, 2025 Auditor Auditor change, Other events8-K items 4.01, 8.01
- Apr 23, 2025 8-K Quarterly results8-K item 2.02
- Apr 21, 2025 SEC letter SEC asked 2 questions about Form 10-Kletters Mar 31, 2025 to Apr 21, 2025 · Results discussion (MD&A)
- Mar 11, 2025 8-K Material agreement signed, New debt or obligation, Other events8-K items 1.01, 2.03, 8.01
- Feb 26, 2025 Planned sale Lawson Macartney (Director) ended a 10b5-1 trading planreported in the 10-K, up to 38,000 shares
- Feb 26, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 5, 2025 8-K Quarterly results8-K item 2.02
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 5, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 29, 2026 | 10-Q | Quarterly report |
| Oct 28, 2026 | 8-K | Quarterly results |
| Sep 28, 2026 | 8-K | Material agreement signed, New debt or obligation |
| Sep 25, 2026 | 424B5 | Prospectus |
| Sep 25, 2026 | 424B5 | Prospectus |
| Sep 24, 2026 | FWP | Offering terms |
| Sep 24, 2026 | 305B2 | |
| Sep 23, 2026 | 424B5 | Prospectus |
| Sep 23, 2026 | 424B5 | Prospectus |
| Sep 22, 2026 | 8-K | Other events |
| Aug 7, 2026 | 4 | Insider trade |
| Aug 7, 2026 | 3 | New insider |
| Jul 30, 2026 | S-3ASR | Shelf registration |
| Jul 29, 2026 | 144 | Notice of planned insider sale |
| Jul 29, 2026 | 144 | Notice of planned insider sale |
| Jul 29, 2026 | 144 | Notice of planned insider sale |
| Jul 29, 2026 | 4 | Insider trade |
| Jul 29, 2026 | 4 | Insider trade |
| Jul 29, 2026 | 4 | Insider trade |
| Jul 29, 2026 | 10-Q | Quarterly report |
| Jul 29, 2026 | 8-K | Quarterly results |
| Jun 3, 2026 | 4 | Insider trade |
| Jun 3, 2026 | 3 | New insider |
| May 26, 2026 | 8-K | Shareholder vote results |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 30, 2026 | 10-Q | Quarterly report |
| Apr 29, 2026 | 8-K | Quarterly results |
| Apr 1, 2026 | ARS | Annual report to shareholders |
| Apr 1, 2026 | DEFA14A | Extra proxy material |
| Apr 1, 2026 | DEF 14A | Proxy statement |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 10, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 10-K | Annual report |
| Feb 11, 2026 | 8-K | Quarterly results |
| Jan 26, 2026 | 4 | Insider trade |
| Jan 26, 2026 | 3 | New insider |
| Jan 5, 2026 | 144 | Notice of planned insider sale |
| Jan 5, 2026 | 144 | Notice of planned insider sale |
| Jan 5, 2026 | 144 | Notice of planned insider sale |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 2, 2026 | 144 | Notice of planned insider sale |
| Nov 5, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 28, 2025 | 144 | Notice of planned insider sale |
| Oct 28, 2025 | 144 | Notice of planned insider sale |
| Oct 28, 2025 | 144 | Notice of planned insider sale |
| Oct 28, 2025 | 4 | Insider trade |
| Oct 28, 2025 | 4 | Insider trade |
| Oct 28, 2025 | 4 | Insider trade |
| Oct 28, 2025 | 4 | Insider trade |
| Oct 27, 2025 | 144 | Notice of planned insider sale |
| Oct 23, 2025 | 10-Q | Quarterly report |
| Oct 22, 2025 | 8-K | Quarterly results |
| Aug 19, 2025 | 8-K | Regulation FD disclosure |
| Aug 6, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 23, 2025 | 10-Q | Quarterly report |
| Jul 23, 2025 | 8-K | Quarterly results |
| Jul 3, 2025 | 144 | Notice of planned insider sale |
| Jul 3, 2025 | 144 | Notice of planned insider sale |
| Jul 3, 2025 | 144 | Notice of planned insider sale |
| Jul 3, 2025 | 4 | Insider trade |
| Jul 3, 2025 | 4 | Insider trade |
| Jul 3, 2025 | 4 | Insider trade |
| May 27, 2025 | 8-K | Shareholder vote results |
| May 12, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Apr 24, 2025 | 10-Q | Quarterly report |
| Apr 23, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Apr 23, 2025 | DEFA14A | Extra proxy material |
| Apr 23, 2025 | DEFR14A | |
| Apr 23, 2025 | 8-K | Quarterly results |
| Apr 23, 2025 | 8-K | Auditor change, Other events |
| Apr 21, 2025 | UPLOAD | Letter from SEC staff |
| Apr 14, 2025 | 4 | Insider trade |
| Apr 8, 2025 | 4/A | Insider trade (amended) |
| Apr 8, 2025 | CORRESP | Company's reply to the SEC |
| Apr 8, 2025 | ARS | Annual report to shareholders |
| Apr 8, 2025 | DEFA14A | Extra proxy material |
| Apr 8, 2025 | DEF 14A | Proxy statement |
| Apr 2, 2025 | 4 | Insider trade |
| Mar 31, 2025 | UPLOAD | Letter from SEC staff |
| Mar 11, 2025 | 8-K | Material agreement signed, New debt or obligation, Other events |
| Feb 26, 2025 | 10-K | Annual report |
| Feb 5, 2025 | 8-K | Quarterly results |
| Feb 4, 2025 | SCHEDULE 13G | 5%+ owner (passive) |
| Jan 6, 2025 | 144 | Notice of planned insider sale |
| Jan 6, 2025 | 144 | Notice of planned insider sale |
| Jan 6, 2025 | 144 | Notice of planned insider sale |
| Jan 6, 2025 | 4 | Insider trade |
| Jan 6, 2025 | 4 | Insider trade |
| Jan 6, 2025 | 4 | Insider trade |
| Jan 6, 2025 | 4 | Insider trade |
| Jan 6, 2025 | 4 | Insider trade |
| Jan 6, 2025 | 4 | Insider trade |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/VKTX/export.csv") into a cell.